Full-Time

Principal Scientist

Materials Science

Confirmed live in the last 24 hours

Pfizer

Pfizer

10,001+ employees

Develops and manufactures biopharmaceutical products

Social Impact
Biotechnology
Healthcare

Compensation Overview

$99.9k - $171.5kAnnually

+ Bonus

Senior

No H1B Sponsorship

Groton, CT, USA

Category
Lab & Research
Life Sciences
Medical Research
Physical Sciences
Required Skills
Data Analysis

You match the following Pfizer's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • A Ph.D. in chemistry, engineering, materials science, or pharmaceutics (or equivalent subject) at least 4 years of relevant experience.
  • Experience in powder characterization (such as polarized light microscopy, electron microscopy, image analysis, laser diffraction methods, etc) and surface property testing (e.g., inverse gas chromatography, EDX, atomic force microscopy, etc) for fine powders.
  • Strong data analysis skills and knowledge of statistical concepts
  • A strong interest and motivation to learn new experimental and computational technologies and concepts
  • Good organizational skills, the ability to work independently, and excellent oral and written communication skills
  • Strong foundational understanding of basic principles of physical, organic and analytical chemistry.
Responsibilities
  • Develop particle and surface characterization tests for developing robust drug products that meet manufacturability, stability and bioperformance requirements.
  • Conduct physical and surface characterization of powders of pharmaceutical relevance. This includes particle characterization (e.g., particle size, shape) and surface characterization (e.g., surface energy, surface roughness).
  • Apply state-of-the-art computational approaches to predict the properties and performance of powder samples.
  • Oversee the work of external partners conducting laboratory studies and provide tactical guidance and critical analysis of raw data.
  • Participate on multidisciplinary project teams and collaborate with colleagues to define and implement characterization strategies according to project timelines.
  • Provide materials science support for colleagues in other departments as well as collaborate with project teams in defining the drug development strategy.
  • Draft and review sections of regulatory submissions.
  • Coaches and mentors laboratory scientists in the design, execution, and analysis of materials science data.
  • Lead the development of new scientific approaches and knowledge within the global Materials Science organization.
Desired Qualifications
  • Experience with using contemporary computational approaches to predict the properties and performance of pharmaceutical materials
  • Understanding of the physical properties needed for drug substance manufacture and formulation into drug product
  • Experience in particle/powder characterization (such as polarized light microscopy, electron microscopy, image analysis, laser diffraction methods, etc) and surface property testing (e.g. EDX, atomic force microscopy, etc) for fine powders

Pfizer focuses on creating and producing healthcare products, particularly medicines and vaccines. The company conducts extensive research and development to discover new treatments, which are then manufactured and sold globally. Pfizer's products include vaccines, cancer treatments, and other specialized medications. A key aspect of Pfizer's operations is its collaboration with BioNTech to develop a vaccine for COVID-19, showcasing its role in addressing public health challenges. Unlike many competitors, Pfizer emphasizes not only the development of new drugs but also the distribution of vaccines to underserved communities. The company's goal is to enhance public health by expanding its range of effective treatments and ensuring access to its products worldwide.

Company Stage

IPO

Total Funding

$3.8B

Headquarters

New York City, New York

Founded

1849

Simplify Jobs

Simplify's Take

What believers are saying

  • Starboard Value's $1 billion stake may drive strategic changes and increase shareholder value.
  • Pfizer's investment in fibrosis treatments expands its therapeutic areas.
  • Involvement in protein modification research diversifies Pfizer's treatment offerings.

What critics are saying

  • Slowdown in COVID-19 vaccine demand impacts Pfizer's revenue streams.
  • Activist investor Starboard Value may influence Pfizer's strategic decisions.
  • Emerging biotech companies pose a threat to Pfizer's market share in immunotherapy.

What makes Pfizer unique

  • Pfizer's partnership with BioNTech led to a highly effective COVID-19 vaccine.
  • Pfizer invests in AI disease models, enhancing predictive insights for drug development.
  • Pfizer's oncology portfolio is strengthened by investments in TCR-based immunotherapies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Paid Holidays

Hybrid Work Options

Relocation Assistance